Clinical Trials Logo

Clinical Trial Summary

Evaluate the efficacy of a sequential regimen of 14 days in patients with catheter-related bacteremia by S. aureus methicillin-susceptible, selected based on a pre-established clinical and microbiological criteria.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01875263
Study type Interventional
Source Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Contact
Status Terminated
Phase Phase 3
Start date May 2013
Completion date November 2014

See also
  Status Clinical Trial Phase
Completed NCT02967432 - Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU Phase 2
Active, not recruiting NCT04946500 - Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)
Completed NCT04625478 - Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections